PDEX

Pro-Dex Inc.

Price

$63.49

return (12m)

36.68%

p/e

16.70

p/bv

4.44

DIVIDEND YIELD

0.00%

PDEX price

Pro-Dex

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment PDEX

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

11.04%

3 months

-1.98%

1 year

36.68%

2 years

188.92%

5 years

147.04%

10 years

1,077.94%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals PDEX

Valuation

P/E

16.70

Sector -0.16

Industry 2.77

P/BV

4.44

Sector 1.93

Industry 2.37

P/Revenue (PSR)

2.69

Sector 1.67

Industry 1.97

EV/EBITDA

Sector -55.30

Industry -73.25

EV/EBIT

Sector -488.87

Industry -73.47

P/EBITDA

Sector -178.48

Industry -262.99

P/EBIT

Sector -214.62

Industry -268.43

P/Total Assets

2.68

Sector 0.91

Industry 1.07

P/Net Current Assets

8.38

Sector -24.70

Industry -5.25

P/Working Capital

5.13

Sector -5.32

Industry 3.11

EPS

4.00

Sector -0.79

Industry -0.61

BVPS

15.07

Sector 3.79

Industry 4.57

Efficiency

Gross Margin

27.78%

Sector 48.28%

Industry 50.49%

EBITDA Margin

0.00%

Sector -5,407,515.68%

Industry -10.73%

EBIT Margin

0.00%

Sector -62.93%

Industry -21.31%

Operating Margin

86.71%

Sector -23.12%

Industry -27.36%

Net Profit Margins

16.09%

Sector -27.40%

Industry -30.91%

Asset Turnover

0.27

Sector 0.13

Industry 0.15

Profitability

ROE

26.57%

Sector -31.93%

Industry -27.86%

ROA

16.02%

Sector -28.25%

Industry -27.56%

ROIC

0.00%

Sector -317.33%

Industry -57.09%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

0.00%

Sector -

Industry -

Debt

Current Ratio

3.67

Sector 1.85

Industry 1.98

Net Debt / EBITDA

Sector -42.46

Industry -72.45

Net Debt / EBIT

Sector -37.26

Industry -7.11

Net Debt / Equity

0.09

Sector -1.04

Industry -0.12

Gross Debt / Equity

0.09

Sector -0.72

Industry 0.10

Equity/Assets

0.60

Sector 0.43

Industry 0.45

Liabilities/Assets

0.40

Sector 0.48

Industry 0.51

Growth

5Y Revenue CAGR

12.54%

Sector -

Industry -

5Y Earnings CAGR

13.74%

Sector -

Industry -

FAIR VALUE OF Pro-Dex ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current price

$63.49

Fair Value

$36.83

Upside Return potential.

-41.99%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals PDEX

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
PDEX Pro-Dex Inc.	$63.49	39.54%	0.00%	16.70	4.44	26.57%	16.09%
ISRG Intuitive Surgical Inc.	$371.80	-21.09%	0.00%	41.88	7.23	17.26%	28.62%
ABT Abbott Laboratories	$112.42	-12.47%	2.33%	33.60	3.57	10.61%	11.65%
MDT Medtronic PLC	$91.17	3.05%	3.09%	24.60	2.36	9.59%	13.20%
BSX Boston Scientific Corp.	$46.77	-55.83%	0.00%	17.71	0.00	-%	19.57%
TMDX TransMedics Group Inc.	$91.75	-20.34%	0.00%	21.60	6.32	29.28%	22.69%
IDXX IDEXX Laboratories Inc.	$553.20	-13.68%	0.00%	38.78	27.41	70.67%	25.03%
RMD ResMed Inc.	$238.60	-14.30%	1.04%	22.12	5.18	23.41%	27.44%
COHR Coherent Inc.	$282.51	211.44%	0.00%	115.66	4.75	4.11%	6.85%
PHG Koninklijke Philips NV	$26.71	0.25%	3.68%	20.31	1.99	9.80%	6.30%
SYK Stryker Corp.	$327.50	-15.63%	1.06%	33.67	5.23	15.55%	14.43%
INMD InMode Ltd.	$14.84	-2.34%	0.00%	11.50	1.42	12.32%	20.69%
DXCM DexCom Inc.	$90.49	18.47%	0.00%	34.80	13.27	38.14%	20.12%
EW Edwards Lifesciences Corp.	$90.23	11.53%	0.00%	51.94	4.86	9.36%	15.41%
BDX Becton Dickinson and Company	$189.33	-0.19%	2.21%	55.38	2.14	3.86%	6.30%
ALGN Align Technology Inc.	$157.75	11.11%	0.00%	28.99	2.83	9.77%	9.99%
ABMD Abiomed Inc.	$0.00	-	0.00%	64.27	11.14	17.32%	24.84%
IRMD iRadimed Corporation	$87.75	20.18%	1.42%	49.15	11.14	22.66%	26.71%
SNN Smith & Nephew PLC	$28.91	-19.76%	2.63%	11.09	2.41	21.74%	9.20%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

PDEX Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Pro-Dex

Pro-Dex Inc.

Average Investor10 user rating

4.0 (1 people)

United States

24 years

Founded: 2002

1986

Time since IPO - 40 years

118

Employees

Pro-Dex Inc. (United States) is listed on the Nasdaq and has a market capitalization of $200.58 million, with shareholders equity totaling $45.20 million.

The company employs approximately 118 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Pro-Dex Inc. reported $74.63 million in revenue, generating net income of $12.01 million.

Key financial metrics include a P/E ratio of 16.70, a price-to-book (P/B) ratio of 4.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker PDEX.

Market cap

$200.58 million

Net worth

$45.20 million

$45,200,000.00

Assets

$74.98 million

$74,980,000.00

Total Shares Outstanding

3.00 million

3,000,000

Average Daily Trading Volume

$88.39 Thousand

$88,392.26

Sector

Health

Industry

Medical Supplies and Equipment

PDEX

PDEX revenue and profits

Financial Results PDEX

DRAG THE FRAME TO SEE MORE DATA

PDEX cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

CVS - CVS Health

$93.51 31,87% (12M)

P/E

-0.84

2.83%

ROE

-178.93%

P/BV

1.51

CI - Cigna

$279.22 --4,61% (12M)

P/E

10.77

2.20%

ROE

16.04%

P/BV

1.73

CNC - Centene

$64.37 121,66% (12M)

P/E

-6.35

0.00%

ROE

-22.56%

P/BV

1.43

HUM - Humana

$390.51 30,46% (12M)

P/E

35.82

0.92%

ROE

6.72%

P/BV

2.41

SNY - Sanofi

$44.84 --5,80% (12M)

P/E

7.43

3.87%

ROE

18.43%

P/BV

1.37

LLY - Eli Lilly

$1,169.97 60,50% (12M)

P/E

41.58

0.52%

ROE

P/BV

HCA - HCA Healthcare

$419.06 4,42% (12M)

P/E

12.08

0.70%

ROE

-244.72%

P/BV

-29.56

NVS - Novartis

$153.04 23,28% (12M)

P/E

28.21

1.96%

ROE

27.47%

P/BV

7.75